The Point Of Care Infectious Disease Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Point Of Care Infectious Disease Testing Market?
The Point Of Care Infectious Disease Testing Global Market has experienced a significant increase in its market size in recent years. It is projected to expand from $4.21 billion in 2024 to $4.79 billion in 2025, reflecting a compound annual growth rate (
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Point Of Care Infectious Disease Testing Industry?
The Point Of Care Infectious Disease Testing Global Market is forecasted to grow to a size of $8.02 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 13.7%.
Download Your Free Sample of the 2025 Point Of Care Infectious Disease Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Point Of Care Infectious Disease Testing Market?
The key drivers in the point of care infectious disease testing market are:
• Rising demand for rapid diagnostics
• Increasing prevalence of infectious diseases
• Growing adoption in remote and resource-limited settings
• Shift toward decentralized healthcare and growing government support
Global Market Segmentation: Identifying Major Point Of Care Infectious Disease Testing Industry Segments
The point of care infectious disease testing market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments
2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases
4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users
Pre-order the 2025 Point Of Care Infectious Disease Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Point Of Care Infectious Disease Testing Market?
The key trends in the point of care infectious disease testing market are:
• Advancements in molecular diagnostics are key emerging trends in this market.
• The development of advanced point of care testing devices will shape the future of the market.
• Innovation in biosensors and detection technologies is a significant trend.
• The adoption and advancement of mobile health applications and innovative partnerships between healthcare providers and tech companies is standing out as an emerging trend.
Who Are the Top Competitors & Leading Players in the Point Of Care Infectious Disease Testing Market?
Major players in the point of care infectious disease testing market are:
• Cardinal Health
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Siemens Healthineers AG
• Becton Dickinson and Company
• Quest Diagnostics Incorporated
• bioMérieux Société Anonyme
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• DiaSorin Società per Azioni
• Danaher Corporation
• Cue Health Inc.
• Nova Biomedical Corporation
• Seegene Incorporated
• Biosynex Société Anonyme
• Trivitron Healthcare Private Limited
• EKF Diagnostics Holdings plc
• Trinity Biotech Public Limited Company
• bioLytical Laboratories Inc.
Regional Dominance: Which Area Leads the Global Point Of Care Infectious Disease Testing Market?
North America was the largest region in the point of care infectious disease testing market in 2024
